Skip to main content

UMMY19160/Hyperbaric Oxygen/ Omar Aljitawi

Research Question:
Is treatment in a hyperbaric oxygen chamber safe and effective for patients with a type of cancer called multiple myeloma?

Basic Study Information

Subjects with multiple myeloma (MM) who are considered eligible for high-dose therapy and autologous stem cell transplantation by the transplant team at WCI will be enrolled in the study.

Study Reference #: STUDY00006189

Lead Researcher (Principal Investigator)

Lead Researcher:  Omar Aljitawi

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email:

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search